724452-72-6

Basic information

• Product Name: 4-(bromomethyl)-N-methoxy-N-methylbenzamide
• Synonyms: 4-(bromomethyl)-N-methoxy-N-methylbenzamide
• CAS NO: 724452-72-6
• Molecular Weight: 258.115
• Mol File: 724452-72-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 4-(bromomethyl)-N-methoxy-N-methylbenzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(bromomethyl)-N-methoxy-N-methylbenzamide(724452-72-6)
• EPA Substance Registry System: 4-(bromomethyl)-N-methoxy-N-methylbenzamide(724452-72-6)

Safety Data

• Hazardous Substances Data: 724452-72-6(Hazardous Substances Data)

Upstream product

• 874-60-2 4-methyl-benzoyl chloride 
• 122334-36-5 N-methoxy-N,4-dimethylbenzamide 
• 99-94-5 p-Toluic acid 

Downstream Products

• 33859-55-1 2-[4-(4-methylbenzoyl)phenyl]acetonitrile 
• 885605-36-7 5-(tert-butyloxycarbonylamino)-2,2-dimethyl-5-(4-octylphenethyl)-1,3-dioxane 
• 1004539-31-4 tert-butyl [2,2-dimethyl-5-(4-octanoylphenethyl)-1,3-dioxan-5-yl]carbamate 
• 1004539-30-3 tert-butyl (5-{4-[methoxy(methyl)carbamoyl]phenethyl}-2,2-dimethyl-1,3-dioxan-5-yl)carbamate 
• 1004539-09-6 4-{(benzo[d]thiazol-2-ylsulfonyl)methyl}-N-methoxy-N-methylbenzamide 
• 1004539-27-8 (E)-tert-butyl [2,2-dimethyl-5-(4-octanoylstyryl)-1,3-dioxan-5-yl]carbamate 
• 1004539-23-4 (E)-tert-butyl (5-{4-[methoxy(methyl)carbamoyl]styryl}-2,2-dimethyl-1,3-dioxan-5-yl)carbamate 

Relevant articles and documents

DIHYDROPYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS

The present invention is directed to dihydropyrazolopyrimidinonecompounds of formula (I) which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis, Parkinson's disease, Parkinson's disease dementia (PDD), or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

Weinreb amide based new synthetic equivalents for convenient access to immunosuppressive agent FTY720 and analogues

Three new synthetic equivalents containing Weinreb amide functionality for the central core of FTY720, an immunosuppressive agent, have been developed. These synthetic equivalents enabled incorporation of the polar head group of FTY720, through Julia, Wit